BioInnovation Institute chief business officer Bobby Soni shares how the life sciences incubator sources entrepreneurs and science globally, and the range of tools it provides to translate this into commercially viable companies.
The problem with Europe’s much discussed fragmented life sciences market, in contrast with US hubs like Boston, is perhaps most acute at the earliest stage. The continent’s abundance of scientists can struggle to find the resources to develop their hypotheses to the point where venture capital comes into play.
The Copenhagen, Denmark-based BioInnovation Institute (BII) aims to fill this crucial gap in the life sciences journey. This comes down...
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.
